PAVmed Past Earnings Performance

Past criteria checks 2/6

PAVmed's earnings have been declining at an average annual rate of -17.2%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 75.6% per year.

Key information

-17.2%

Earnings growth rate

4.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate75.6%
Return on equityn/a
Net Margin364.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%?

Jan 29
Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%?

Is PAVmed (NASDAQ:PAVM) Using Debt In A Risky Way?

Aug 17
Is PAVmed (NASDAQ:PAVM) Using Debt In A Risky Way?

PAVmed Non-GAAP EPS of -$0.17 beats by $0.03

Aug 16

PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress

Jul 05

Start Accumulating PAVmed

Dec 24

We Think PAVmed (NASDAQ:PAVM) Can Afford To Drive Business Growth

Sep 02
We Think PAVmed (NASDAQ:PAVM) Can Afford To Drive Business Growth

PAVmed: Long Term Investment Case Remains Despite Weak Q2

Aug 23

PAVmed: A True Game-Changer For Medical Device Innovation

Jun 14

PAVmed forms digital health company, Veris Health

Jun 02

PAVmed's subsidiary receives CE mark for EsoCheck esophageal cell collection device

May 26

PAVmed (NASDAQ:PAVM) Is In A Good Position To Deliver On Growth Plans

May 19
PAVmed (NASDAQ:PAVM) Is In A Good Position To Deliver On Growth Plans

PAVmed drops 14% on launch of $13.4M direct offering

Jan 06

PAVmed closes additional direct offering of common stock

Dec 22

Do Institutions Own PAVmed Inc. (NASDAQ:PAVM) Shares?

Dec 16
Do Institutions Own PAVmed Inc. (NASDAQ:PAVM) Shares?

PAVmed offers stock for $8.9M

Dec 11

PAVmed EPS beats by $0.02

Nov 17

There Is Progress At PAVmed, But More Patience Is Required

Oct 30

Revenue & Expenses Breakdown

How PAVmed makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:PAVM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24415449
30 Jun 244-674510
31 Mar 243-714512
31 Dec 232-664914
30 Sep 232-715317
30 Jun 231-795720
31 Mar 231-906223
31 Dec 220-896125
30 Sep 221-865726
30 Jun 221-725025
31 Mar 221-584322
31 Dec 211-513420
30 Sep 210-422617
30 Jun 210-352014
31 Mar 210-301512
31 Dec 200-351211
30 Sep 200-321110
30 Jun 200-30108
31 Mar 200-2898
31 Dec 190-1787
30 Sep 190-1776
30 Jun 190-1775
31 Mar 190-1975
31 Dec 180-1964
30 Sep 180-1263
30 Jun 180-1463
31 Mar 180-1053
31 Dec 170-1053
30 Sep 170-1253
30 Jun 170-953
31 Mar 170-952
31 Dec 160-642
30 Sep 160-541
30 Jun 160-331
31 Mar 160-221
31 Dec 150-210

Quality Earnings: PAVM has a large one-off gain of $64.7M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: PAVM became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PAVM has become profitable over the past 5 years, growing earnings by -17.2% per year.

Accelerating Growth: PAVM has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PAVM has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (20.7%).


Return on Equity

High ROE: PAVM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 01:38
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PAVmed Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Raymond MyersBenchmark Company
Charles DuncanCantor Fitzgerald & Co.